The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Journal of Comparative Effectiveness Research
(Sep 2024)
Why is the market design for innovative pharmaceuticals not well understood?
Francisco Olivenca,
Jose Diaz,
Sreeram V Ramagopalan,
Louis P Garrison Jr
Affiliations
Francisco Olivenca
Lane Clark & Peacock LLP, London, W1U 1DQ, UK
Jose Diaz
Global Health Economics & Outcomes Research, Bristol Myers Squibb, Uxbridge, UB8 1DH, UK
Sreeram V Ramagopalan
Lane Clark & Peacock LLP, London, W1U 1DQ, UK; Centre for Pharmaceutical Medicine Research, King’s College London, SE1 9NH, UK
Louis P Garrison Jr
The Comparative Health Outcomes, Policy, & Economics (CHOICE) Institute, University of Washington, Seattle, WA 98195-7630, USA
DOI
https://doi.org/10.57264/cer-2024-0105
Journal volume & issue
Vol. 13, no. 10
Abstract
Read online
No abstracts available.
Keywords
innovation
market design
pharmaceuticals
pricing
research and development costs
value
WeChat QR code
Close